- Expenditure and resource utilisation for cervical screening in Australia
Jie Bin Lew
Cancer Research Division, Cancer Council NSW, 153 Dowling Street, Woolloomooloo, Sydney, NSW 2011, Australia
BMC Health Serv Res 12:446. 2012
..This study aimed to provide a baseline for such a review by quantifying screening program resource utilisation and costs in 2010...
- Hybrid Capture II testing for high-risk human papillomavirus DNA in the follow-up of women treated for high-grade cervical intraepithelial neoplasia
Jeffrey H J Tan
Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia
J Low Genit Tract Dis 17:308-14. 2013
- The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey
Oncology and Dysplasia Unit, The Royal Women s Hospital, Parkville, Victoria, Australia
Aust N Z J Obstet Gynaecol 50:472-7. 2010
..With human papilloma virus (HPV) vaccines now approved for women up to 45 years of age, gynaecologists in Australia will be approached increasingly for advice on whether to have the HPV vaccine...
- New technologies and advances in colposcopic assessment
Jeffrey H J Tan
Oncology and Dysplasia Unit, Royal Women s Hospital, Parkville, Victoria, Australia
Best Pract Res Clin Obstet Gynaecol 25:667-77. 2011
..Opportunities remain for global collaboration in research, education and training to promote more effective and affordable cervical screening, and to enhance the skills of colposcopists worldwide...
- Clearance of human papillomavirus in women treated for cervical dysplasia
Elya E Moore
Department of Microbiology and Infectious Diseases, Royal Women s Hospital, Parkville, Victoria, Australia
Obstet Gynecol 117:101-8. 2011
..To estimate human papillomavirus (HPV) clearance of women with cervical abnormalities after treatment...
- Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results
Matthew P Stevens
Department of Microbiology, The Royal Women s Hospital, 132 Grattan Street, Carlton, Victoria 3053, Australia
J Clin Microbiol 45:2130-7. 2007
..Both PCR-based HPV tests may be valuable in the management of care for women with underlying cervical abnormalities, in predicting treatment success, and in studying the clearance or acquisition of new infections...
- Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia
Department of Oncology and Dysplasia, Royal Women s Hospital, Parkville, Victoria, Australia
Aust N Z J Obstet Gynaecol 49:426-8. 2009
..This study aims to determine if the lack of an endocervical component in women with previously treated high-grade abnormalities of the cervix increases the risk of subsequent cytological abnormalities...
- Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
Elisa J Young
Department of Microbiology and Infectious Diseases, Royal Women s Hospital, Parkville, Melbourne, VIC 3052, Australia
BMC Cancer 13:296. 2013
..In sub study B, the distribution of human papillomavirus genotypes detected in high grade cervical intraepithelial neoplastic lesions from vaccine eligible women is being assessed...
- Confocal endomicroscopy: a novel imaging technique for in vivo histology of cervical intraepithelial neoplasia
Royal Women s Hospital, Carlton, Victoria, Australia
Expert Rev Med Devices 4:863-71. 2007
- Should the Pap smear be repeated at the first colposcopy visit?
The University Department of Obstetrics and Gynaecology and Oncology Dysplasia Unit, Royal Women s Hospital, Melbourne, Australia
Aust N Z J Obstet Gynaecol 45:514-7. 2005
..To determine whether there is any benefit in repeating the Pap smear at the time of colposcopy in women referred to a teaching hospital dysplasia clinic...